Berlin, Mannheim / Germany, June 02, 2016: The Biosimilars Group and CCDRD AG, a German based CRO, have today announced a partnership to bring more effort/progress in the development of biosimilars.
TBG – THE ALLIANCE FOR YOUR SUCCESS
5 specialized partners, each with its solid core competence, form one unique team to develop your biosimilar.
With any combination of services be sure:
Our experience, efficiency and flexibility will make your drug-to-market project a success.
The Biosimilars Group is a one-stop solution provider to realize complex biosimilar projects tailored to your specific requirements.
From Cell to Marketing Authorization –
Combined Excellence in Biosimilars Development
UNIQUE EXPERT SUPPORT
All members of The Biosimilars Group are renowned service providers dedicated to the global development of biosimilars specialized in key areas:
The Biosimilars Group is covering all aspects of biosimilars development from candidate identification to marketed product.
POWER BY MULTIPLICITY
Interdisciplinary teams achieve tailor-made solutions.
We would be pleased to provide you with further information about The Biosimilars Group, our capabilities and our services.